background
achillea
kellalensi
frequent
use
chaharmah
va
bakhtiarian
resid
southwest
iran
tradit
herbal
medicin
treatment
acut
diarrhea
select
examin
antivir
activ
bovin
rotaviru
cell
toxic
activ
cell
object
aim
studi
evalu
vitro
cytotox
antirotaviru
properti
crude
extract
kellalensi
materi
method
dri
powder
flower
achillea
kellalensi
extract
hot
water
ethanol
vv
cell
viabil
toxic
extract
evalu
cell
use
four
method
trypan
blue
dye
nr
crystal
violet
mtt
assay
vitro
antirotaviru
properti
determin
via
four
differ
assay
order
evalu
direct
inhibit
andor
inhibit
viral
replic
result
cytotox
two
kellalensi
extract
show
differ
concentr
hydroalcohol
extract
low
cc
nr
assay
aqueou
extract
high
cc
crystal
violet
method
simultan
treatment
assay
post
treatment
assay
extract
abl
prevent
viral
replic
inhibit
viral
cpe
cell
tcid
extract
exhibit
direct
antivir
activ
rotaviru
adsorpt
effect
concentr
ec
extract
observ
conclus
result
indic
kellalensi
extract
exert
potent
antirotavir
activ
viral
adsorpt
two
extract
kellalensi
show
good
select
index
also
result
suggest
extract
prepar
flower
kellalensi
may
potenti
antirotavir
agent
vivo
use
veterinari
medicin
studi
describ
vitro
cytotox
antirv
properti
crude
extract
kellalensi
collect
chaharmah
va
bakhtiari
also
test
action
mechan
extract
determin
whether
directli
inhibit
rotaviru
bind
cell
andor
inhibit
viral
replic
rotavirus
major
etiolog
agent
caus
sever
acut
dehydr
gastroenter
young
children
wide
varieti
domest
anim
viru
transmit
fecalor
rout
clinic
sign
rotaviru
infect
includ
acut
gastroenter
fever
vomit
abdomin
pain
diarrhea
dehydr
rhiniti
year
rotaviru
caus
estim
million
hospit
death
children
worldwid
known
treatment
rotaviru
gastroenter
support
therapi
replac
fluid
electrolyt
lost
vomit
diarrhea
oral
immunoglobulin
also
use
treat
diarrhea
caus
rotavirus
howev
costli
unknown
sideeffect
two
oral
attenu
reassort
rotaviru
vaccin
rotarix
rotateq
may
prevent
rotaviru
infect
infant
young
children
nt
approv
infant
immunosuppress
ill
also
vaccin
effect
popul
greatest
risk
develop
countri
asia
africa
remain
assess
therefor
necessari
develop
new
antivir
agent
viru
plant
rich
broad
rang
secondari
metabolit
flavonoid
polysaccharid
alkaloid
terpenoid
tannin
phenol
amino
acid
found
vitro
antimicrobi
antivir
properti
sever
antivir
plant
extract
black
tea
citru
aurantium
marin
spong
soy
isoflavon
stevia
rebaudiana
alpinia
katsumadai
found
inhibitori
rotavirus
vitro
less
toxic
fewer
sideeffect
cheaper
howev
drug
current
avail
human
anim
use
none
yet
clinic
use
renew
interest
search
new
antirotavir
agent
genu
achillea
belong
asteracea
composita
largest
famili
flower
vascular
plant
achillea
speci
use
local
peopl
folk
tradit
herbal
medicin
variou
region
throughout
world
achillea
kellalensi
boiss
hausskn
origin
chaharmah
va
bakhtiari
southwest
iran
local
known
golberrenja
bumadaranesabzekohi
consumpt
herbal
tea
prepar
flower
speci
long
use
medicin
plant
especi
treatment
acut
diarrhea
achillea
speci
major
bioactiv
compon
includ
flavonoid
terpenoid
monoterpen
sesquiterpen
diterpen
triterpen
camphor
borneol
lignan
amino
acid
deriv
fatti
acid
alkamid
activ
genu
differ
bacteria
fungi
virus
parasit
might
due
presenc
secondari
activ
metabolit
flavonoid
phenol
acid
terpenoid
sterol
isol
howev
date
antirotaviru
activ
aqueou
hydroalcohol
extract
kellalensi
evalu
present
studi
describ
vitro
cytotox
antirv
properti
crude
extract
kellalensi
collect
chaharmah
va
bakhtiari
kellalensi
flower
clean
airdri
ground
fine
textur
grinder
aqueou
extract
hot
water
extract
ml
boil
distil
water
ad
g
powder
flower
erlenmey
flask
kept
shaker
rpm
h
room
temperatur
brew
extract
filter
gauz
clarifi
centrifug
rpm
minut
supernat
dri
electr
water
bath
hydroalcohol
extract
perform
soak
g
powder
flower
ml
ethanol
kept
shaker
rpm
day
room
temperatur
filter
gauz
extract
filter
whatman
filter
paper
filtrat
evapor
dryness
electr
water
bath
g
dri
extract
suspend
ml
respect
solvent
steril
filtrat
filter
jet
biofil
store
cultur
monolay
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
presenc
penicillin
g
uml
streptomycin
gentamycin
amphotericin
b
humidifi
atmospher
contain
co
air
cytotox
assess
microscop
observ
neutral
red
assay
crystal
violet
assay
mtt
reduct
assay
viabil
cell
determin
trypan
blue
dye
exclus
method
cell
seed
densiti
cell
per
well
medium
plate
nunc
pipett
cell
per
well
ml
medium
cultur
plate
h
incub
co
atmospher
growth
medium
replac
similar
volum
fresh
medium
free
fb
seri
differ
concentr
dose
maximum
mgml
minimum
mgml
herbal
extract
posit
cell
incub
mm
hydrogen
peroxid
neg
control
untreat
cell
receiv
medium
without
extract
prepar
treat
cell
reincub
h
differ
cytotox
assay
highest
concentr
extract
show
cell
toxic
consid
maximum
nontox
concentr
mntc
cytotox
concentr
cc
estim
regress
analysi
mtt
cytotox
assay
carri
slight
modif
previous
describ
mosmann
percentag
cytotox
calcul
ab
mean
optic
densiti
untreat
well
b
mean
optic
densiti
well
plant
extract
extract
obtain
cc
valu
defin
concentr
reduc
absorb
treat
cell
compar
untreat
cell
determin
regress
analysi
nr
assay
cheap
sensit
method
cytotox
test
procedur
perform
use
miner
modif
method
previous
describ
plate
prepar
similarl
describ
mtt
reduct
assay
crystal
violet
pb
minut
plate
rins
twice
water
dri
invers
filter
paper
enumer
measur
absorb
nm
elisa
reader
bio
rad
report
valu
mean
replic
percentag
cytotox
calcul
similar
describ
mtt
reduct
assay
determin
number
viabl
cell
trypan
blue
exclus
method
perform
end
treatment
period
plate
h
seri
variou
concentr
extract
replic
mlwell
medium
remov
cell
detach
well
trypsinedta
solut
solut
includ
detach
cell
centrifug
rpm
min
supernat
remov
detach
cell
well
stain
trypan
blue
dye
transfer
hematocytomet
count
use
optic
microscop
olympu
cell
viabil
percentag
calcul
divis
total
count
number
viabl
cell
total
cell
viabil
minim
viabil
cell
incub
mm
hydrogen
peroxid
result
total
cell
death
evid
trypan
blue
viabil
stain
posit
control
untreat
cell
receiv
medium
without
extract
use
maximum
viabil
neg
control
report
valu
mean
replic
viru
titrat
confluent
monolay
cell
perform
limitdilut
method
tenfold
serial
dilut
viru
stock
made
dmem
free
fb
trypsin
tpck
treat
titer
propag
viral
stock
determin
use
mtt
colorimetr
techniqu
crystal
violet
assay
cpe
observ
cell
express
tissu
cultur
infecti
dose
tcid
per
ml
reedmunch
method
determin
titer
tcid
ml
antivir
assay
use
studi
previous
describ
visual
assay
also
perform
method
use
evalu
cell
toxic
mtt
reduct
assay
crystal
violet
method
neutral
red
assay
cpe
observ
describ
follow
microscop
examin
cpe
perform
score
normal
cell
cpe
effect
concentr
ec
defin
reciproc
concentr
extract
requir
prevent
rotavirusinduc
cytolysi
virucid
assay
adsorpt
inhibit
assay
perform
determin
abil
extract
inhibit
decreas
rate
adsorpt
penetr
rotaviru
treat
cell
cell
seed
densiti
cell
per
well
medium
onto
plate
nunc
incub
co
atmospher
h
mix
treatment
assay
virucid
assay
tcid
activ
rotavirus
mix
variou
nontox
concentr
mgml
extract
incub
h
mixtur
ad
well
mlwell
incub
h
solut
remov
cell
wash
pb
remov
remain
extract
well
well
replenish
dmem
contain
trypsin
mlwell
cell
incub
h
co
atmospher
experi
carri
replic
effect
concentr
ec
estim
regress
analysi
cpe
inhibit
assay
perform
determin
whether
extract
prevent
viral
replic
affect
one
step
replic
virus
alreadi
cell
simultan
treatment
assay
cell
seed
previous
describ
incub
period
spent
medium
decant
cell
wash
two
time
use
pb
medium
contain
tcid
activ
rotavirus
differ
nontox
concentr
maximum
mgml
minimum
mgml
crude
extract
ad
well
mlwell
plate
incub
h
humidifi
incub
co
air
atmospher
experi
carri
replic
effect
concentr
ec
estim
regress
analysi
b
post
treatment
assay
viral
replic
inhibit
assay
cell
seed
previous
describ
incub
period
growth
medium
remov
cell
wash
two
time
use
pb
tcid
activ
rotavirus
inocul
onto
well
h
inoculum
remov
cell
monolay
wash
one
time
use
pb
replac
dmem
contain
trypsin
variou
nontox
concentr
mgml
extract
mlwell
cell
incub
h
co
atmospher
experi
carri
replic
effect
concentr
ec
estim
regress
analysi
c
pretreat
assay
h
period
incub
variou
nontox
concentr
mgml
extract
mlwell
ad
cell
incub
h
prior
viru
infect
tcid
well
cell
incub
h
co
atmospher
experi
carri
replic
effect
concentr
ec
estim
regress
analysi
control
consist
viru
control
well
untreatedinfect
cell
viru
without
extract
toxic
control
well
treat
noninfect
cell
variou
concentr
crude
extract
without
viru
cell
control
well
untreat
noninfect
cell
receiv
medium
contain
trypsin
without
extract
viru
use
simultan
cc
ec
extract
calcul
concentrationeffect
curv
regress
analysi
therapeut
index
ti
select
index
si
extract
defin
ratio
maximum
drug
concentr
growth
normal
cell
inhibit
cc
minimum
drug
concentr
viru
inhibit
ec
si
cc
ec
cytotox
two
achillea
kellalensi
extract
show
differ
concentr
hydroalcohol
extract
low
cc
nr
assay
aqueou
extract
high
cc
crystal
violet
method
tabl
figur
grow
cell
treat
variou
concentr
achillea
kellalensi
extract
viabil
measur
trypan
blue
dye
exclus
method
cell
decreas
viabil
increas
concentr
observ
aqueou
hydroalcohol
extract
show
viabil
respect
data
shown
figur
inhibitori
effect
kellalensi
bovin
rotaviru
examin
method
use
evalu
cell
toxic
extract
flower
achillea
kellalensi
shown
effect
bovin
rotaviru
result
antivir
assay
kellalensi
extract
depict
tabl
simultan
treatment
assay
post
treatment
assay
extract
abl
prevent
viral
replic
inhibit
viral
cpe
cell
tcid
effect
concentr
ec
extract
observ
order
test
abil
two
kellalensi
extract
inhibit
adsorpt
bovin
rotavirus
cell
virucid
assay
use
howev
contrast
simultan
treatment
assay
post
treatment
assay
inhibitori
effect
rotaviru
shown
virucid
assay
pretreat
assay
extract
exhibit
direct
antivir
activ
rotaviru
adsorpt
present
result
support
ethnomed
use
kellalensi
antirotaviru
agent
first
report
antirotavir
cytotox
activ
kellalensi
result
indic
method
examin
determin
cell
toxic
extract
neutral
red
assay
sensit
timeofaddit
experi
carri
evalu
step
kellalensi
extract
exert
inhibitori
activ
extract
abl
inhibit
viral
replic
prevent
format
cpe
infect
cell
present
studi
simultan
treatment
assay
result
agreement
post
treatment
assay
result
indic
kellalensi
extract
could
probabl
exert
potenti
antirotaviru
activ
via
blockag
rna
synthesi
howev
virucid
assay
extract
abl
inhibit
decreas
rate
adsorpt
penetr
rotaviru
treat
cell
extract
abl
inhibit
viral
replic
amount
viru
increas
tcid
examin
concentr
result
indic
kellalensi
extract
exert
potent
antirotavir
activ
viral
adsorpt
two
extract
kellalensi
show
good
select
index
kellalensi
tradit
medicin
herb
long
use
treat
acut
gastriti
wound
heal
activ
antihypertens
antihyperlipidem
effect
antioxid
activ
estrogen
activ
antidiabet
activ
antispermatogen
effect
antiulc
activ
antibacteri
antifung
activ
antiepimastigot
activ
antivir
activ
antispasmod
activ
antiinflammatori
activ
variou
speci
achillea
report
earlier
investig
achillea
fragrantissima
extract
examin
vitro
antipolioviru
activ
signific
antivir
activ
also
observ
activ
kellalensi
extract
bovin
rota
viru
might
due
presenc
secondari
activ
metabolit
flavonoid
phenol
acid
shown
possess
block
rna
synthesi
activ
point
data
demonstr
kellalensi
extract
potent
antirotaviru
effect
vitro
howev
investig
requir
explor
antirotaviru
activ
vivo
bovin
rotaviru
strain
calv
murin
rotaviru
strain
mice
consid
rotavirus
caus
sever
diarrhea
mortal
calv
econom
loss
dairi
industri
therefor
use
herb
use
veterinari
medicin
